Scott Rocklage is a Mover and Shaker in the Investment Community

Scott Rocklage, Ph.D. is the managing partner at 5AM Ventures, a role he took on in 2004. He initially joined 5AM Ventures in 2003 as a Venture Partner. Dr. Rocklage has more than 30 years experience in healthcare management, as well as a scientific background that has reinforced his background. His leadership responsibilities were a major factor in obtaining FDA (Federal Drug Administration) approval for three new drug applications and include Cubicin, Teslascan and Omniscan. 5AM Ventures operates offices in San Francisco, California and Waltham, Massachusetts. Dr. Rocklage is located in Waltham.

Before joining 5AM, Scott was the Chairman and Chief Operating Officer (CEO) of Cubist Pharmaceuticals and President and CEO of Nycomed Salutar. While at Salutar and Catalytica, Dr. Rocklage held several R&D (Research and Design) positions. Rocklage also served as CEO and President at Amersham Health, Executive Chairman and Co-President of Ilypsa, Inc. Other positions he has held is Chairman of the Board at Cidara Therapeutics, Inc and the Chairman of Novra Therapeutics, Inc. His background has added to his wide range of experience in healthcare, science and strategic leadership roles and made him a very effective leader and strategist in the world of pharmaceuticals, healthcare and venture capital.

Rocklage’s educational background includes earning a Bachelor of Science (BS) degree in Chemistry from the University of California, Berkley and a Doctor of Philosophy (Ph.D.) degree in Chemistry from the Massachusetts Institute of Technology (MIT). While at MIT, Rocklage conducted research in the laboratory of Richard R. Schrock, a Nobel Prize winner in Chemistry in 2005. Dr. Rocklage is also an inventor or co-inventor of more than 30 U.S. Patents. He has also authored more than 100 publications subject to peer review.

Through Dr. Rocklage’s leadership, 5AM Ventures has become one of the venture capital company’s focused on life science companies looking to the next generation. 5AM Ventures supports entities that are developing solutions to solve healthcare needs utilizing cutting edge breakthroughs in science and medicine. Companies subject to 5AM support are on the forefront of developing untraditional approaches to diagnose, prevent and treat a wide variety of medical conditions.

The team at 5AM all has very strong finance, legal, business operational, medical and scientific backgrounds. The collection of backgrounds provides a unique, as well as cutting edge style to find and manage life science companies. Rocklage’s philosophy is to take a hand-on approach to building the companies, as well as providing the early investment dollar. 5AM takes on all roles related to managing and operating a business and includes serving as board members, operations managers and strategists, mostly for the short term. His hands on approach have proved to be a winning component in the scientific equation to finding the right companies and forging investment opportunities.

Source:

http://www.prnewswire.com/news-releases/scott-m-rocklage-phd-joins-5am-ventures-72545982.html

Leave a Reply

Your email address will not be published. Required fields are marked *